Difference between revisions of "Elijah Odoyo-June"
(Created page with "'''{{FULLPAGENAME}}''' is member of the 2018 Guideline Development Group (GDG) of the WHO. The GDG's task is to develop updated recommendations on safe male circumcision f...") |
m (add DEFAULTSORT) |
||
| Line 16: | Line 16: | ||
Elijah Odoyo-June is a medical doctor with postgraduate training in public health and a PhD in Tropical and infectious Diseases. He has over 20 years of progressive responsibilities in clinical and preventive health care including research experience in the fields of Reproductive health, HIV/AIDS, health systems development in Kenya and Malawi. His recent research experiences in male circumcision include coordination of long term follow up of clients enrolled in the Randomized controlled trial of Male Circumcision for HIV prevention in Kisumu Kenya, study of wound healing following medical circumcision of HIV +ve and HIV-ve adult males in Kisumu; safety and acceptability of Early Infant Male circumcision in Kisumu, study of effectiveness and safety of [[Prepex|PrePex]] for circumcision in Kenya and active AE surveillance for ShangRing circumcision. | Elijah Odoyo-June is a medical doctor with postgraduate training in public health and a PhD in Tropical and infectious Diseases. He has over 20 years of progressive responsibilities in clinical and preventive health care including research experience in the fields of Reproductive health, HIV/AIDS, health systems development in Kenya and Malawi. His recent research experiences in male circumcision include coordination of long term follow up of clients enrolled in the Randomized controlled trial of Male Circumcision for HIV prevention in Kisumu Kenya, study of wound healing following medical circumcision of HIV +ve and HIV-ve adult males in Kisumu; safety and acceptability of Early Infant Male circumcision in Kisumu, study of effectiveness and safety of [[Prepex|PrePex]] for circumcision in Kenya and active AE surveillance for ShangRing circumcision. | ||
| − | He currently serves as technical lead for [[CDC]]/[[PEPFAR]] supported Medical Male circumcision program in Kenya; providing technical and programmatic guidance for all aspects of [[VMMC]] implementation. As long serving member of Kenya’s national [[VMMC]] TWG he has a rich experience in development of standard operating procedures and guidelines for [[VMMC]] service delivery in Kenya and other African countries. | + | He currently serves as technical lead for [[CDC]]/[[PEPFAR]] supported Medical Male circumcision program in Kenya; providing technical and programmatic guidance for all aspects of [[VMMC]] implementation. As long serving member of Kenya’s national [[VMMC]] TWG he has a rich experience in development of standard operating procedures and guidelines for [[VMMC]] service delivery in Kenya and other African countries.<ref>{{REFdocument |
| − | <ref>{{REFdocument | ||
|url=https://www.who.int/hiv/mediacentre/news/WHOVMMCGDG-Sep2018.pdf?ua=1 | |url=https://www.who.int/hiv/mediacentre/news/WHOVMMCGDG-Sep2018.pdf?ua=1 | ||
|title=Biographies of Guideline Development Group (GDG) members for WHO guidance | |title=Biographies of Guideline Development Group (GDG) members for WHO guidance | ||
| Line 28: | Line 27: | ||
{{REF}} | {{REF}} | ||
| + | |||
| + | {{DEFAULTSORT:Odoyo-June, Elijah}} | ||
[[Category:Africa]] | [[Category:Africa]] | ||
Revision as of 10:52, 26 March 2020
Elijah Odoyo-June is member of the 2018 Guideline Development Group (GDG) of the WHO. The GDG's task is to develop updated recommendations on safe male circumcision for HIV prevention and related service delivery for adolescent boys and men in generalized HIV epidemics.[1]
Biography
The WHO published the following biography of Elijah Odoyo-June:
Odoyo-June, Elijah
- US Centers for Disease Control and Prevention (CDC), Kenya
- MBchB, MSc, PhD
- Nairobi, Kenya
Elijah Odoyo-June is a medical doctor with postgraduate training in public health and a PhD in Tropical and infectious Diseases. He has over 20 years of progressive responsibilities in clinical and preventive health care including research experience in the fields of Reproductive health, HIV/AIDS, health systems development in Kenya and Malawi. His recent research experiences in male circumcision include coordination of long term follow up of clients enrolled in the Randomized controlled trial of Male Circumcision for HIV prevention in Kisumu Kenya, study of wound healing following medical circumcision of HIV +ve and HIV-ve adult males in Kisumu; safety and acceptability of Early Infant Male circumcision in Kisumu, study of effectiveness and safety of PrePex for circumcision in Kenya and active AE surveillance for ShangRing circumcision.
He currently serves as technical lead for CDC/PEPFAR supported Medical Male circumcision program in Kenya; providing technical and programmatic guidance for all aspects of VMMC implementation. As long serving member of Kenya’s national VMMC TWG he has a rich experience in development of standard operating procedures and guidelines for VMMC service delivery in Kenya and other African countries.[2]
References
- ↑
(May 2018). WHO to develop new guidelines on male circumcision
. Retrieved 26 March 2020. - ↑
Biographies of Guideline Development Group (GDG) members for WHO guidance 
, WHO. (September 2018). Retrieved 26 March 2020.
.svg){kind=icon}
